Study of long-term transplant survivors at one Belgian hospital
Part of Blood & lymphatic clinical trials.
This study invites adults who had a donor (allogeneic) transplant at KU Leuven long ago to share health information during a scheduled checkup. It may help researchers better understand long-term outcomes and support needs after transplant.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be able to read and write in Dutch
- You must be older than 18 years at the time of your transplant
- You must have received an allogeneic donor transplant at KU Leuven between 1992 and 2012 (and be at least 2 years out)
- You need to come for the periodic health check at KU Leuven between Nov 15, 2014 and Nov 15, 2016
- You must be willing to give consent (both oral and written)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks how people do long-term after stem cell transplant, cellular therapy, or gene therapy. It may help doctors track longer-term health effects and recovery and improve future care.
This study follows kidney, liver, or heart transplant recipients to better understand how to improve their long-term health and survival. Researchers at several hospitals in France will collect information from participants to learn what helps people stay healthy after a transplant.
This study follows people who are at least 3 years out from their first stem cell transplant to learn how they are doing long term. It may help improve future transplant care by tracking outcomes over time.
This study follows children born to mothers who had a solid organ transplant (like kidney, liver, or heart) to learn about their long-term health. It may help doctors understand how to better care for these families.
This study looks at how having an allogeneic stem cell transplant affects quality of life, how patients make transplant decisions, and the financial impact—especially for people living on Réunion Island. It includes patients who are planning this transplant in mainland France and will answer questionnaires.
This study tracks patients who have had or are planning to have a stem cell transplant. It helps doctors learn more about long-term outcomes and improve care for future patients.
Hear when a new Hematopoietic Stem Cell Transplantation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.